Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Histone deacetylase inhibitors in cancer therapy.

× No keyword cloud information.

14 in total

1. The histone deacetylase inhibitor valproic acid lessens NK cell action against oncolytic virus-infected glioblastoma cells by inhibition of STAT5/T-BET signaling and generation of gamma interferon.

Authors: Christopher A Alvarez-Breckenridge; Jianhua Yu; Richard Price; Min Wei; Yan Wang; Michal O Nowicki; Yoonhee P Ha; Stephen Bergin; Christine Hwang; Soledad A Fernandez; Balveen Kaur; Michael A Caligiuri; E Antonio Chiocca
Journal: J Virol Date: 2012-02-08 Impact factor: 5.103

Review 2. How can we trick the immune system into overcoming the detrimental effects of oncolytic viral therapy to treat glioblastoma?

Authors: Walter H Meisen; Balveen Kaur
Journal: Expert Rev Neurother Date: 2013-04 Impact factor: 4.618

3. Sirtuin 6 Attenuates Kaposi's Sarcoma-Associated Herpesvirus Reactivation by Suppressing Ori-Lyt Activity and Expression of RTA.

Authors: Min Hu; Najealicka Armstrong; Edward Seto; Wenwei Li; Fanxiu Zhu; Paul C Wang; Qiyi Tang
Journal: J Virol Date: 2019-03-21 Impact factor: 5.103

4. (Bis)urea and (bis)thiourea inhibitors of lysine-specific demethylase 1 as epigenetic modulators.

Authors: Shiv K Sharma; Yu Wu; Nora Steinbergs; Michael L Crowley; Allison S Hanson; Robert A Casero; Patrick M Woster
Journal: J Med Chem Date: 2010-07-22 Impact factor: 7.446

5. Histone deacetylase inhibitor romidepsin enhances anti-tumor effect of erlotinib in non-small cell lung cancer (NSCLC) cell lines.

Authors: Wei Zhang; Michael Peyton; Yang Xie; Junichi Soh; John D Minna; Adi F Gazdar; Eugene P Frenkel
Journal: J Thorac Oncol Date: 2009-02 Impact factor: 15.609

6. Polyaminohydroxamic acids and polyaminobenzamides as isoform selective histone deacetylase inhibitors.

Authors: Sheeba Varghese; Thulani Senanayake; Tracey Murray-Stewart; Kim Doering; Alison Fraser; Robert A Casero; Patrick M Woster
Journal: J Med Chem Date: 2008-03-19 Impact factor: 7.446

7. Mechanistic studies on the effects of nicotinamide on megakaryocytic polyploidization and the roles of NAD+ levels and SIRT inhibition.

Authors: Lisa M Giammona; Swapna Panuganti; Jan M Kemper; Pani A Apostolidis; Stephan Lindsey; Eleftherios T Papoutsakis; William M Miller
Journal: Exp Hematol Date: 2009-08-26 Impact factor: 3.084

Histone deacetylase inhibitors in cancer therapy.